loading
전일 마감가:
$119.24
열려 있는:
$121.84
하루 거래량:
544.43K
Relative Volume:
0.82
시가총액:
$7.41B
수익:
$3.91B
순이익/손실:
$394.92M
주가수익비율:
-79.59
EPS:
-1.57
순현금흐름:
$1.02B
1주 성능:
+0.55%
1개월 성능:
+10.46%
6개월 성능:
+16.81%
1년 성능:
+5.65%
1일 변동 폭
Value
$120.07
$125.10
1주일 범위
Value
$115.65
$125.10
52주 변동 폭
Value
$99.06
$134.17

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
명칭
Jazz Pharmaceuticals Plc
Name
전화
353-1-634-7800
Name
주소
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
직원
2,800
Name
트위터
@jazzpharma
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
JAZZ's Discussions on Twitter

JAZZ을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
JAZZ 125.01 7.41B 3.91B 394.92M 1.02B -1.57
VRTX 450.44 115.43B 10.63B -479.80M -1.35B 13.33
REGN 749.43 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 589.59 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.53 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.84 24.89B 3.30B -501.07M 1.03B 11.54

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-01-03 개시 Robert W. Baird Outperform
2023-11-27 다운그레이드 UBS Buy → Neutral
2023-09-29 개시 Raymond James Mkt Perform
2023-06-12 재개 Wells Fargo Equal Weight
2022-12-09 업그레이드 Goldman Neutral → Buy
2022-06-14 개시 UBS Buy
2022-04-06 다운그레이드 Goldman Buy → Neutral
2021-11-19 재개 Goldman Buy
2021-10-07 재개 Jefferies Buy
2021-10-05 개시 Citigroup Buy
2021-09-23 개시 Needham Buy
2021-05-19 재개 JP Morgan Overweight
2021-04-07 재개 RBC Capital Mkts Outperform
2021-02-05 재확인 H.C. Wainwright Buy
2021-02-03 업그레이드 Piper Sandler Neutral → Overweight
2021-01-29 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-12-16 개시 UBS Buy
2020-11-03 재확인 H.C. Wainwright Buy
2020-10-09 재확인 H.C. Wainwright Buy
2020-09-14 다운그레이드 Goldman Neutral → Sell
2020-09-14 재개 JP Morgan Overweight
2020-08-06 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-07-28 업그레이드 Wolfe Research Peer Perform → Outperform
2020-07-23 업그레이드 H.C. Wainwright Neutral → Buy
2020-04-06 개시 Jefferies Buy
2020-03-12 업그레이드 Bernstein Mkt Perform → Outperform
2020-01-08 개시 Goldman Neutral
2019-08-21 다운그레이드 Piper Jaffray Overweight → Neutral
2019-06-11 개시 Barclays Overweight
2019-03-20 개시 SunTrust Buy
2018-12-14 개시 Wolfe Research Peer Perform
2018-11-08 재확인 B. Riley FBR Buy
2018-08-08 재확인 Stifel Buy
2018-07-11 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2018-03-23 재확인 H.C. Wainwright Neutral
2018-03-19 업그레이드 Morgan Stanley Equal-Weight → Overweight
모두보기

Jazz Pharmaceuticals Plc 주식(JAZZ)의 최신 뉴스

pulisher
01:21 AM

JAZZ Secures FDA Approval For Ziihera In Biliary Tract Cancer - Barchart

01:21 AM
pulisher
11:01 AM

U.S. STOCKS Jazz Pharmaceuticals, SPAR, Alphabet - XM

11:01 AM
pulisher
09:09 AM

Pacer Advisors Inc. Buys 278,465 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

09:09 AM
pulisher
09:08 AM

Thompson Siegel & Walmsley LLC Increases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

09:08 AM
pulisher
08:57 AM

FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework - Benzinga

08:57 AM
pulisher
08:10 AM

John G Ullman & Associates Inc. Sells 11,400 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

08:10 AM
pulisher
08:08 AM

Jazz Pharmaceuticals stock trades at discount amid diversification efforts By Investing.com - Investing.com UK

08:08 AM
pulisher
06:53 AM

Jazz stock Zymeworks stock gain on FDA nod (JAZZ:NASDAQ) - Seeking Alpha

06:53 AM
pulisher
06:00 AM

Zymeworks' Ziihera Wins FDA Approval: First Dual HER2 Cancer Drug Shows 52% Response Rate | ZYME Stock News - StockTitan

06:00 AM
pulisher
01:33 AM

JAZZ (Jazz Pharmaceuticals) COGS-to-Revenue : 0.11 (As of Sep. 2024) - GuruFocus.com

01:33 AM
pulisher
Nov 20, 2024

Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment - Reuters.com

Nov 20, 2024
pulisher
Nov 20, 2024

Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) - JAZZ's Investor Relations

Nov 20, 2024
pulisher
Nov 19, 2024

Jazz Pharmaceuticals to Present at Citi's 2024 Global Healthcare Conference | JAZZ Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment - Insider Monkey

Nov 19, 2024
pulisher
Nov 18, 2024

Jazz Pharmaceuticals: High Uncertainty, Low Risk (undefined:JAZZ) - Seeking Alpha

Nov 18, 2024
pulisher
Nov 18, 2024

Jazz Pharmaceuticals shares target raised on patient base growth By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 18, 2024

Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now? - Insider Monkey

Nov 18, 2024
pulisher
Nov 18, 2024

Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $162.00 Price Target at Robert W. Baird - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Victory Capital Management Inc. Has $28.22 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Jazz Tops Q3 Earnings & Sales Estimates, Raises '24 EPS View - MSN

Nov 17, 2024
pulisher
Nov 17, 2024

Los Angeles Capital Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Jazz Pharmaceuticals Plc: Its Efforts Towards Zepzelca Frontline Therapy Expansion & Other Major Drivers - Smartkarma

Nov 16, 2024
pulisher
Nov 16, 2024

KBC Group NV Has $25.44 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Principal Financial Group Inc. Trims Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Idiopathic Hypersomnia Treatment Market will experience - openPR

Nov 15, 2024
pulisher
Nov 14, 2024

Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock? - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

We Think Jazz Pharmaceuticals' (NASDAQ:JAZZ) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St

Nov 14, 2024
pulisher
Nov 14, 2024

Jazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Jazz Pharmaceuticals' EVP Neena Patil sells $456,617 in shares By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) PT at $175.00 - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Jazz Pharmaceuticals' EVP Neena Patil sells $456,617 in shares - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Jazz (JAZZ) Upgraded to Buy: Here's Why - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

JAZZ or CTLT: Which Is the Better Value Stock Right Now? - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Kovack Advisors Inc. - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High? - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

American Assets Inc. Invests $557,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

Jazz Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

Jazz Pharmaceuticals plc Updates Earnings Guidance for the Full Year 2024 - Marketscreener.com

Nov 11, 2024
pulisher
Nov 11, 2024

Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know - Yahoo Finance

Nov 11, 2024
pulisher
Nov 10, 2024

28,693 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by CWA Asset Management Group LLC - MarketBeat

Nov 10, 2024
pulisher
Nov 10, 2024

Amalgamated Bank Sells 9,681 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 10, 2024
pulisher
Nov 08, 2024

Philip James Wealth Mangement LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024
pulisher
Nov 08, 2024

Van ECK Associates Corp Increases Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Jazz Pharmaceuticals plc (JAZZ) Quarterly 10-Q Report - Quartzy

Nov 07, 2024
pulisher
Nov 07, 2024

Jazz Pharma revenues rise 9% in third quarter | Pharmaceutical | The Pharmaletter - The Pharma Letter

Nov 07, 2024
pulisher
Nov 07, 2024

Jazz Pharmaceuticals' (JAZZ) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Robeco Institutional Asset Management B.V. Sells 19,161 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Jazz Pharmaceuticals PLC (JAZZ) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Nov 07, 2024

Jazz Pharmaceuticals Plc (JAZZ) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):